NCT02038777 2025-02-26
A Study Of PF-04449913 In Japanese Patients With Select Hematologic Malignancies
Pfizer
Phase 1 Completed
Clinical Trials
4 trialsNCT00953758 2024-04-25
A Study Of PF-04449913 In Select Hematologic Malignancies
Pfizer
Phase 1 Completed
NCT01286467 2024-03-06
A Study Of PF-04449913 Administered Alone In Select Solid Tumors
Pfizer
Phase 1 Completed
NCT04655391 2022-06-09
Glasdegib-Based Treatment Combinations for the Treatment of Patients With Relapsed Acute Myeloid Leukemia Who Have Undergone Hematopoietic Cell Transplantation
City of Hope Medical Center
Phase 1 Withdrawn